F Bogetto

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. ncbi Recognition and treatment of dysthymia in elderly patients
    S Bellino
    Department of Neuroscience, Psychiatric Unit, University of Turin, Torino, Italy
    Drugs Aging 16:107-21. 2000
  2. ncbi A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder
    Paola Rocca
    Department of Neuroscience, Psychiatric Section, University of Turin, Via Cherasco 11, 10126 Torino, Italy
    J Affect Disord 70:313-7. 2002
  3. ncbi Treatment of borderline personality disorder with risperidone
    Paola Rocca
    Department of Neuroscience, University of Turin, Italy
    J Clin Psychiatry 63:241-4. 2002
  4. ncbi Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial
    F Bogetto
    Service for Depressive and Anxiety Disorders, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126, Turin, Italy
    Psychiatry Res 96:91-8. 2000
  5. ncbi Gender-related differences in the onset of panic disorder
    G Barzega
    Department of Neurosciences, University of Turin, Italy
    Acta Psychiatr Scand 103:189-95. 2001
  6. ncbi Clinical features of dysthymia and age: a clinical investigation
    S Bellino
    Depressive and Anxiety Disorders Unit, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126, Turin, Italy
    Psychiatry Res 103:219-28. 2001
  7. ncbi Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose
    S Bellino
    Centre for Personality Disorders, Unit of Psychiatry 1, Department of Neurosciences, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Curr Med Chem 18:3322-9. 2011
  8. ncbi Dysthymic disorder: clinical characteristics in relation to age at onset
    G Barzega
    Department of Neurosciences, Psychiatry Section, University of Turin, Turin, Italy
    J Affect Disord 66:39-46. 2001
  9. ncbi Bulimia nervosa with and without obsessive-compulsive syndromes
    U Albert
    Department of Neuroscience, Psychiatric Unit, University of Turin, Italy
    Compr Psychiatry 42:456-60. 2001
  10. ncbi Relapses after discontinuation of drug associated with increased resistance to treatment in obsessive-compulsive disorder
    G Maina
    Department of Neuroscience, University of Turin, Italy
    Int Clin Psychopharmacol 16:33-8. 2001

Collaborators

Detail Information

Publications66

  1. ncbi Recognition and treatment of dysthymia in elderly patients
    S Bellino
    Department of Neuroscience, Psychiatric Unit, University of Turin, Torino, Italy
    Drugs Aging 16:107-21. 2000
    ..All these topics need to be further investigated in studies comparing the elderly with control groups of younger patients with dysthymia...
  2. ncbi A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder
    Paola Rocca
    Department of Neuroscience, Psychiatric Section, University of Turin, Via Cherasco 11, 10126 Torino, Italy
    J Affect Disord 70:313-7. 2002
    ..The purpose of this study was to provide preliminary data on the effects of paroxetine and amisulpride on depressive dimensions, analyzed by factor analysis, in dysthymic patients...
  3. ncbi Treatment of borderline personality disorder with risperidone
    Paola Rocca
    Department of Neuroscience, University of Turin, Italy
    J Clin Psychiatry 63:241-4. 2002
    ..Our purpose was to assess the efficacy of risperidone in BPD, focusing on its effects on impulsive-aggressive behavior...
  4. ncbi Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial
    F Bogetto
    Service for Depressive and Anxiety Disorders, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126, Turin, Italy
    Psychiatry Res 96:91-8. 2000
    ..It appears that augmentation of olanzapine in fluvoxamine-refractory OCD may be effective in a large number of patients, including those with comorbid schizotypal personality disorder...
  5. ncbi Gender-related differences in the onset of panic disorder
    G Barzega
    Department of Neurosciences, University of Turin, Italy
    Acta Psychiatr Scand 103:189-95. 2001
    ..Life events showed a significant role in precipitating PD onset in women. CONCLUSION: Premorbid clinical conditions of PD seem to differentiate between males and females in the role of precipitating events...
  6. ncbi Clinical features of dysthymia and age: a clinical investigation
    S Bellino
    Depressive and Anxiety Disorders Unit, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126, Turin, Italy
    Psychiatry Res 103:219-28. 2001
    ..The data suggested different etiologic pathways in older and younger patients. Dysthymia appeared to be associated in younger adults with abnormalities of personality; in the elderly, with a history of health problems and life losses...
  7. ncbi Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose
    S Bellino
    Centre for Personality Disorders, Unit of Psychiatry 1, Department of Neurosciences, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Curr Med Chem 18:3322-9. 2011
    ..Effects of antidepressants on impulsive behaviours are uncertain. Further studies are needed to improve methods of trials and confirm these findings...
  8. ncbi Dysthymic disorder: clinical characteristics in relation to age at onset
    G Barzega
    Department of Neurosciences, Psychiatry Section, University of Turin, Turin, Italy
    J Affect Disord 66:39-46. 2001
    ..Although they are not actually related to age at onset, some interesting findings emerged in the symptomatological characterization of the disorder, referring to the diagnostic criteria proposed in DSM-IV...
  9. ncbi Bulimia nervosa with and without obsessive-compulsive syndromes
    U Albert
    Department of Neuroscience, Psychiatric Unit, University of Turin, Italy
    Compr Psychiatry 42:456-60. 2001
    ..Moreover, in these patients, obsessive-compulsive symptoms are undistinguishable from those of OCD females, and exert a negative influence on the clinical picture of the bulimic disorder...
  10. ncbi Relapses after discontinuation of drug associated with increased resistance to treatment in obsessive-compulsive disorder
    G Maina
    Department of Neuroscience, University of Turin, Italy
    Int Clin Psychopharmacol 16:33-8. 2001
    ..Findings from our study, together with literature data indicating high relapse rates when discontinuing the treatment after the acute phase, support the idea of continuing the treatment in OCD over the long term...
  11. ncbi Occurrence and clinical correlates of psychiatric co-morbidity in delusional disorder
    G Maina
    Department of Neuroscience, Psychiatric Unit, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Eur Psychiatry 16:222-8. 2001
    ....
  12. ncbi Gender-related distribution of personality disorders in a sample of patients with panic disorder
    G Barzega
    Department of Neuroscience, Psychiatry, Section Via Cherasco 11 10126, Torino, Italy
    Eur Psychiatry 16:173-9. 2001
    ....
  13. ncbi Outcome and length of stay in psychiatric hospitalization, the experience of the University Clinic of Turin
    Paola Rocca
    Psychiatric Section, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126, Turin, Italy
    Soc Psychiatry Psychiatr Epidemiol 45:603-10. 2010
    ..Given the current tendency to shorten psychiatric hospitalization and change its organization, an issue could be raised regarding its outcomes...
  14. ncbi Lymphocyte peripheral benzodiazepine receptor mRNA decreases in obsessive-compulsive disorder
    P Rocca
    Department of Neuroscience, Section of Psychiatry, University of Turin, Via Cherasco 11, 10126 Torino, Italy
    Eur Neuropsychopharmacol 10:337-40. 2000
    ..We suggest that modulation of pBR gene expression might delineate a clinical heterogeneity in OCD...
  15. ncbi Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study
    S Bellino
    Service for Personality Disorders, Unit of Psychiatry, Department of Neurosciences, University of Turin, Turin, Italy
    J Psychopharmacol 24:333-9. 2010
    ..Adverse effects were mild headache and nausea. Initial results suggest that duloxetine is an effective and well-tolerated treatment for BPD, with positive effects on somatic symptoms...
  16. ncbi A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression
    G Rosso
    Mood and Anxiety Disorders Unit, Department of Neuroscience, University of Turin, Turin, Italy
    J Affect Disord 136:172-6. 2012
    ..The goal of the present work was to compare in terms of efficacy two different dual-action compounds, duloxetine and bupropion, in patients who failed to respond in two consecutive antidepressant trials with SSRIs...
  17. ncbi Emergency psychiatry
    V Villari
    Emergency Medicine, Psychiatric Emergency Service, Department of Mental Health Turin I South, S Giovanni Hospital, Turin, Italy
    Minerva Med 98:525-41. 2007
    ....
  18. ncbi Management of treatment resistant obsessive-compulsive disorder. Algorithms for pharmacotherapy
    U Albert
    Anxiety and Mood Disorders Unit, Department of Neurosciences, University of Turin, Turin, Italy
    Panminerva Med 44:83-91. 2002
    ....
  19. ncbi Bipolar obsessive-compulsive disorder and personality disorders
    Giuseppe Maina
    Department of Neuroscience, Anxiety and Mood Disorders Unit, University of Turin, Turin, Italy
    Bipolar Disord 9:722-9. 2007
    ..The aim of the present study was to explore the comorbidity of personality disorders in a group of patients with OCD and comorbid bipolar disorder (BD)...
  20. ncbi Combined brief dynamic therapy and pharmacotherapy in the treatment of major depressive disorder: a pilot study
    Giuseppe Maina
    Mood and Anxiety Disorders Unit, Department of Neuroscience, University of Turin, Turin, Italy
    Psychother Psychosom 76:298-305. 2007
    ..The aim of this study is to compare the efficacy of BDT added to medication with that of brief supportive psychotherapy (BSP) added to medication in the treatment of major depressive disorder...
  21. ncbi Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes
    Umberto Albert
    Department of Neurosciences, Mood nad Anxiety Disorders Unit, University of Turin, Italy, Torino, Italy
    J Affect Disord 105:297-303. 2008
    ....
  22. ncbi Health-related quality of life among first-degree relatives of patients with obsessive-compulsive disorder in Italy
    Umberto Albert
    Department of Neuroscience, University of Turin, Italy, Via Cherasco 11, Torino 10126, Italy
    Psychiatr Serv 58:970-6. 2007
    ..The aim of this study was, first, to examine health-related quality of life among relatives of Italian patients with obsessive-compulsive disorder and, second, to search for potential predictors of quality of life among these relatives...
  23. ncbi Neuropsychological correlates of reality distortion in schizophrenic patients
    Paola Rocca
    Department of Neuroscience, Psychiatric Section, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Psychiatry Res 145:49-60. 2006
    ....
  24. ncbi Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study
    Silvio Bellino
    Unit of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy
    J Clin Psychiatry 67:1042-6. 2006
    ..Sparse data are available on the use of quetia-pine in treating this disorder. The aim of the present study is to investigate efficacy and tolerability of quetia-pine in a group of patients with borderline personality disorder...
  25. ncbi Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse
    Giuseppe Maina
    Department of Neuroscience, Mood and Anxiety Disorders Unit, University of Turin, Italy
    J Affect Disord 99:247-51. 2007
    ..In our study we compared the efficacy and safety of valproate and olanzapine added to lithium in the treatment of patients experiencing breakthrough manic episodes while on lithium monotherapy...
  26. ncbi Axis I and II comorbidities in subjects with and without nocturnal panic
    Umberto Albert
    Anxiety and Mood Disorders Unit, Department of Neuroscience, University of Turin, Italy
    Depress Anxiety 23:422-8. 2006
    ..Personality might play a relevant role in influencing treatment approaches to PD, but it does not appear to be a differential focus of concern in patients with compared to those without NP...
  27. ncbi Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study
    Paola Rocca
    Department of Neuroscience, Psychiatric Section, University of Turin, Turin, Italy
    Psychiatry Clin Neurosci 61:622-9. 2007
    ..No significant differences emerged among treatments. The preliminary results also suggest that baseline cognitive function might influence treatment response...
  28. ncbi Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder
    Giuseppe Maina
    Department of Neuroscience, Mood and Anxiety Disorders Unit, University of Turin, Italy
    J Affect Disord 110:149-55. 2008
    ..This investigation explores the association between body weight and bipolar illness in drug-naïve patients...
  29. ncbi Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation
    Vincenzo Villari
    Emergency Department, Psychiatric Emergency Service, S Giovanni Hospital, Corso Bramante 88, 10126 Turin, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 32:405-13. 2008
    ..GENERAL METHODS: We recruited 101 patients with acute psychosis who were admitted at the Mental Health Department 1 South of Turin, Psychiatric Emergency Service of San Giovanni Battista Hospital, from June 2004 to June 2005...
  30. ncbi Efficacy and tolerability of pharmacotherapies for borderline personality disorder
    Silvio Bellino
    Unit of Psychiatry, Department of Neurosciences, Service for Personality Disorders, University of Turin, Turin, Italy
    CNS Drugs 22:671-92. 2008
    ..Initial findings are encouraging for many of these drugs. However, data need to be replicated in further controlled studies with head-to-head comparisons and long-term follow-ups. Many questions remain to be answered...
  31. ncbi Metabolic syndrome in Italian patients with bipolar disorder
    Virginio Salvi
    Department of Neuroscience, Psychiatry Clinic, University of Turin, 10126 Turin, Italy
    Gen Hosp Psychiatry 30:318-23. 2008
    ..This study aimed to evaluate the prevalence of metabolic syndrome (MetS) in Italian patients with bipolar disorder (BD) and to determine the sociodemographic and clinical correlates of MetS in this patient population...
  32. ncbi Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy
    Silvio Bellino
    Department of Neurosciences, University of Turin, Torino, Italy
    Can J Psychiatry 52:718-25. 2007
    ..We compare the effects of 2 combined therapies, fluoxetine and interpersonal therapy (IPT) or fluoxetine and cognitive therapy (CT), on major depression in patients with borderline personality disorder (BPD)...
  33. ncbi Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia
    Hans Jurgen Moller
    Psychiatric Hospital of the University of Munich, Munich, Germany
    Int Clin Psychopharmacol 23:95-105. 2008
    ..In conclusion, efficacy was maintained without compromising safety/tolerability when switching patients with stable schizophrenia from twice-daily quetiapine IR to once-daily quetiapine XR (400-800 mg/day)...
  34. ncbi Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study
    Giuseppe Maina
    Department of Neurosciences, Mood and Anxiety Disorders Unit, University of Turin, Turin, Italy
    J Clin Psychiatry 69:609-16. 2008
    ....
  35. ncbi 8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder
    Giuseppe Maina
    Department of Neurosciences, Mood and Anxiety Disorders Unit, University of Turin, Italy
    Eur Neuropsychopharmacol 18:364-72. 2008
    ....
  36. ncbi Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia
    Paola Rocca
    Department of Neuroscience, Psychiatric Section, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Compr Psychiatry 49:170-6. 2008
    ..The aim of this cross-sectional study was to examine the relationships between attitudes toward antipsychotics, insight, and other clinical variables in stable schizophrenia...
  37. ncbi Early-onset obsessive-compulsive disorder and personality disorders in adulthood
    Giuseppe Maina
    Department of Neurosciences, Mood and Anxiety Disorders Unit, University of Turin, Via Cherasco 11 10126 Torino, Italy
    Psychiatry Res 158:217-25. 2008
    ..Our finding suggests that OCD in childhood increases the risk for developing OCPD in adulthood, or that early-onset OCD and OCPD share a common pathogenesis...
  38. ncbi Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy
    Silvio Bellino
    Unit of Psychiatry, Department of Neuroscience, University of Turin, Torino, Italy
    Can J Psychiatry 51:453-60. 2006
    ..The aim of this study was to compare combined treatment using interpersonal psychotherapy (IPT) with pharmacotherapy alone in patients with depression and borderline personality disorder (BPD)...
  39. ncbi [Multifamily psychoeducational intervention (MPI) for obsessive-compulsive disorder: a pilot study]
    Umberto Albert
    Epidemiol Psichiatr Soc 15:71-6. 2006
  40. ncbi Managing the aggressive and violent patient in the psychiatric emergency
    Paola Rocca
    Department of Neuroscience, Unit of Psychiatry, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 30:586-98. 2006
    ..Based on rather limited evidence, a wide variety of medications for the pharmacological treatment of acute aggression has been recommended: typical and atypical antipsychotics and benzodiazepines...
  41. ncbi Predictors of psychiatric disorders in liver transplantation candidates: logistic regression models
    Paola Rocca
    Department of Neuroscience, Psychiatric Section, University of Turin, Italy
    Liver Transpl 9:721-6. 2003
    ..Severity of liver disease emerges as the most important variable in predicting severity of psychiatric disorders in these patients...
  42. ncbi Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued?
    Giuseppe Maina
    Anxiety and Mood Disorders Unit, University of Turin, Italy
    Int Clin Psychopharmacol 18:23-8. 2003
    ....
  43. ncbi Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression
    Paola Rocc
    Psychiatric Section, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 26:1155-60. 2002
    ..A tempting approach to examine alterations of dopaminergic system in major depression is to examine the expression of dopamine receptors in peripheral blood mononuclear cells (PBMC)...
  44. ncbi Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study
    Umberto Albert
    Anxiety and Mood Disorders Unit, Department of Neurosciences, University of Turin, Italy
    J Clin Psychiatry 63:1004-9. 2002
    ..5% of those receiving clomipramine (43/47). CONCLUSION: Our results indicate that venlafaxine might be as efficacious as clomipramine in the acute treatment of OCD, with fewer side effects...
  45. ncbi A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes
    Paola Rocca
    Department of Neuroscience, Psychiatric Section, University of Turin, Via Cherasco 11, Italy
    Psychiatry Res 112:145-52. 2002
    ..Both treatments appeared to be effective in our sample of dysthymic subjects. Combined treatment with paroxetine and amisulpride resulted in a better outcome in terms of social functioning...
  46. ncbi [Phenomenology of patients with early and adult onset obsessive-compulsive disorder]
    Umberto Albert
    Servizio per i disturbi depressivi e d'ansia, Dipartimento di Neuroscienze, , Torino
    Epidemiol Psichiatr Soc 11:116-26. 2002
    ....
  47. ncbi Sertraline treatment of obsessive-compulsive disorder: efficacy and tolerability of a rapid titration regimen
    Filippo Bogetto
    Anxiety and Mood Disorders Unit, Department of Neurosciences, Psychiatric Section, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Eur Neuropsychopharmacol 12:181-6. 2002
    ..Limitations of the present study are the single-blind design and the lack of power to detect differences in tolerability...
  48. ncbi An exploratory study on obsessive-compulsive disorder with and without a familial component: are there any phenomenological differences?
    Umberto Albert
    Department of Neuroscience, Anxiety and Mood Disorders Unit, University of Turin, Turin, Italy
    Psychopathology 35:8-16. 2002
    ....
  49. ncbi Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation
    Filippo Bogetto
    Unit of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy
    CNS Drugs 16:273-83. 2002
    ..The syndrome is related both to drug and clinical characteristics. The features of the syndrome in patients with different Axis I diagnoses should be compared in further investigations...
  50. ncbi Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study
    Giuseppe Maina
    Department of Neuroscience, University of Turin, Italy
    J Clin Psychiatry 63:38-43. 2002
    ..Double-blind, placebo-controlled trials are needed to further document the efficacy of amisulpride and SSRIs in the treatment of BMS...
  51. ncbi Donepezil in the treatment of Alzheimer's disease: long-term efficacy and safety
    Paola Rocca
    Department of Neuroscience, University of Turin, Italy
    Prog Neuropsychopharmacol Biol Psychiatry 26:369-73. 2002
    ..CONCLUSIONS: Donepezil improved cognition and global functioning and was well tolerated especially considered the long duration of the observation period...
  52. ncbi Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients
    Silvio Bellino
    Unit of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy
    J Clin Psychiatry 65:908-14. 2004
    ....
  53. ncbi DSM-IV obsessive-compulsive personality disorder: prevalence in patients with anxiety disorders and in healthy comparison subjects
    Umberto Albert
    Anxiety and Mood Disorders Unit, Department of Neurosciences, University of Turin, Italy
    Compr Psychiatry 45:325-32. 2004
    ....
  54. ncbi Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors
    Giuseppe Maina
    Mood and Anxiety Disorders Unit, Department of Neuroscience, University of Turin, Torino, Italy
    J Clin Psychiatry 65:1365-71. 2004
    ..The aim of the present study was to assess changes in weight in obsessive-compulsive disorder (OCD) patients treated for 2.5 years with clomipramine or selective serotonin reuptake inhibitors...
  55. ncbi Naturalistic, retrospective comparison between second-generation antipsychotics and depot neuroleptics in patients affected by schizophrenia
    Livio Marchiaro
    Department of Mental Health Turin 1 South, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    J Clin Psychiatry 66:1423-31. 2005
    ..0112). CONCLUSION: These findings confirm at least equal long-term effectiveness of depot neuroleptics and SGAs, but a possible advantage for SGAs in decreased use of anticholinergic drugs...
  56. ncbi Oxcarbazepine in the treatment of borderline personality disorder: a pilot study
    Silvio Bellino
    Unit of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy
    J Clin Psychiatry 66:1111-5. 2005
    ..The present article is a pilot study on the efficacy and tolerability of oxcarbazepine in the treatment of borderline personality disorder...
  57. ncbi Depressive and negative symptoms in schizophrenia: different effects on clinical features
    Paola Rocca
    Department of Neuroscience, Unit of Psychiatry, University of Turin, 10126 Torino, Italy
    Compr Psychiatry 46:304-10. 2005
    ..We also analyzed whether depressive and negative symptoms presented different patterns of predictors...
  58. ncbi Dysmorphic concern symptoms and personality disorders: a clinical investigation in patients seeking cosmetic surgery
    Silvio Bellino
    Unit of Psychiatry, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126 Torino, Italy
    Psychiatry Res 144:73-8. 2006
    ..Preoperative assessment could help to define the clinical profile of patients in cosmetic surgery settings...
  59. ncbi Premorbid conditions and precipitating events in early-onset panic disorder
    Sara Venturello
    Department of Neurosciences, Psychiatry Section, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Compr Psychiatry 43:28-36. 2002
    ..Our findings suggest that the early-onset form of PD seems to be more characterized by endogenous components compared to the adult-onset form...
  60. ncbi Clinical picture of obsessive-compulsive disorder with poor insight: a regression model
    Silvio Bellino
    Unit of Psychiatry, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126 Turin, Italy
    Psychiatry Res 136:223-31. 2005
    ..These results suggest that poor insight identifies a group of OCD patients with distinct clinical characteristics...
  61. ncbi Personality disorders in patients with burning mouth syndrome
    Giuseppe Maina
    Anxiety and Mood Disorders Unit, Department of Neuroscience, University of Turin, Italy
    J Pers Disord 19:84-93. 2005
    ..Our results suggest that BMS is associated with a specific pattern of Axis II comorbidity...
  62. ncbi Major depression in patients with borderline personality disorder: a clinical investigation
    Silvio Bellino
    Department of Neuroscience, University of Turin, Italy
    Can J Psychiatry 50:234-8. 2005
    ..This study aimed to compare the clinical characteristics of 2 groups of patients with MDD: those with concomitant BPD and those with other concomitant personality disorders...
  63. ncbi Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial
    Paola Rocca
    Department of Neurosciences, Psychiatric Section, University of Turin, Via Cherasco, 11 10126 Turin, Italy
    J Clin Psychiatry 66:360-9. 2005
    ....
  64. ncbi Nocturnal panic and recent life events
    Umberto Albert
    Anxiety and Mood Disorders Unit, Department of Neuroscience, University of Turin, Turin, Italy
    Depress Anxiety 22:52-8. 2005
    ..However, the hypothesis that this vulnerability might be determined by life events that occur in the period preceding PD onset was not supported by the findings of this study...
  65. ncbi Randomized controlled trial comparing brief dynamic and supportive therapy with waiting list condition in minor depressive disorders
    Giuseppe Maina
    Mood and Anxiety Disorders Unit, Department of Neuroscience, University of Turin, Via Cherasco, 11, IT 10126 Turin, Italy
    Psychother Psychosom 74:43-50. 2005
    ..The aim of this study was to determine whether BDT is more effective than brief supportive psychotherapy (BSP) and waiting list condition in the treatment of minor depressive disorders...
  66. ncbi Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes
    Giuseppe Maina
    Department of Neurosciences, Mood and Anxiety Disorders Unit, University of Turin, Italy
    J Clin Psychiatry 68:207-12. 2007
    ..We included as comparison samples a group of subjects with recurrent major depression (RMD) and a group of non-psychiatrically ill individuals...